$43.84
0.000.00%
Pre-Market: 4:00 PM EDT
Comments
Loading...
Revolution Medicines (RVMD) Forecast
NewsEarningsRevolution Medicines (RVMD) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestRevolution Medicines (NASDAQ:RVMD) Stock Quotes, Forecast and News Summary
Revolution Medicines Stock (NASDAQ: RVMD) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Revolution Medicines (RVMD) stock?
You can purchase shares of Revolution Medicines (NASDAQ:RVMD) through any online brokerage.
Who are Revolution Medicines (RVMD) competitors?
Other companies in Revolution Medicines’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Ionis Pharmaceuticals (NASDAQ:IONS).
What is the forecast, or price target, for Revolution Medicines (RVMD) stock?
Revolution Medicines has a consensus price target of $56.84.
What is the current price for Revolution Medicines (RVMD)?
The stock price for Revolution Medicines (NASDAQ: RVMD) is $43.84 last updated January 6, 2025 at 4:00 PM EST.
Does Revolution Medicines (RVMD) pay a dividend?
There are no upcoming dividends for Revolution Medicines.
When is Revolution Medicines (NASDAQ:RVMD) reporting earnings?
Revolution Medicines’s Q4 earnings are confirmed for Monday, February 24, 2025.
Is Revolution Medicines (RVMD) going to split?
There is no upcoming split for Revolution Medicines.
What sector and industry does Revolution Medicines (RVMD) operate in?
Revolution Medicines is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.